Glucagon-like peptide-1 7-36 amide
Alternative Names: GLP-1 (7-36) amideLatest Information Update: 24 Oct 2021
At a glance
- Originator Nonindustrial source
- Developer Nonindustrial source; Novo Nordisk
- Class Glucagon-like peptides
- Mechanism of Action Gastric inhibitory polypeptide stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Obesity; Type 2 diabetes mellitus
Most Recent Events
- 29 Jun 2004 Discontinued - Clinical-Phase-Unknown for Obesity in Denmark (Infusion)
- 29 Jun 2004 Discontinued - Clinical-Phase-Unknown for Obesity in Sweden (Infusion)
- 29 Jun 2004 Discontinued - Clinical-Phase-Unknown for Obesity in USA (Infusion)